Clinical Trial Update: Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease [Phase 1]

View source ↗

Summary

Phase 1 safety study of the DENV-1 PIV dengue vaccine has completed; the document provides an update on the trial status for dengue fever.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• DENV-1 PIV

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue Fever | Phase 1 | Status: COMPLETED